Potent and selective azaindole inhibitors of CDK8 and CDK19
US12410194B2 · kind B2 · utility
0Cited by
3References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 25, 2020 |
| Grant date | Sep 9, 2025 |
| Priority date | — |
| Expiry date | Jan 11, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D495/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with CDK8 and/or CDK19.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.